0001683168-23-003496.txt : 20230517 0001683168-23-003496.hdr.sgml : 20230517 20230517161543 ACCESSION NUMBER: 0001683168-23-003496 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20230517 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Coeptis Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001759186 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 981465952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39669 FILM NUMBER: 23931910 BUSINESS ADDRESS: STREET 1: 105 BRADFORD ROAD, SUITE 420 CITY: WEXFORD STATE: PA ZIP: 15090 BUSINESS PHONE: 724-934-6467 MAIL ADDRESS: STREET 1: 105 BRADFORD ROAD, SUITE 420 CITY: WEXFORD STATE: PA ZIP: 15090 FORMER COMPANY: FORMER CONFORMED NAME: Bull Horn Holdings Corp. DATE OF NAME CHANGE: 20181115 8-K 1 coeptis_8k.htm CURRENT REPORT
0001759186 false 0001759186 2023-05-17 2023-05-17 0001759186 us-gaap:CommonStockMember 2023-05-17 2023-05-17 0001759186 us-gaap:WarrantMember 2023-05-17 2023-05-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 8-K

_____________________

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): May 17, 2023

_____________________

 

COEPTIS THERAPEUTICS HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 001-39669 98-1465952

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

     

105 Bradford Rd, Suite 420

Wexford, Pennsylvania

   15090
(Address of principal executive offices)   (Zip Code)

 

724-934-6467

(Registrant’s telephone number, including area code)

 

____________________________________________________________

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock, par value $0.0001 per share

  

COEP

 		  

Nasdaq Global Market

Warrants, each whole warrant exercisable for one-half of one share of Common Stock for $11.50 per whole share

  

COEPW

  

Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company     ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ☐

 

 

   
 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers 

 

Departure of Christine Sheehy as Chief Financial Officer

 

On May 17, 2023, Coeptis Therapeutics, Inc. (NASDAQ GLOBAL: COEP) (the “Company”) announced that Christine Sheehy is stepping down from her role as Chief Financial Officer of the Company, effective immediately. Ms. Sheehy will remain with the Company to support the finance team and also in her new roles as Vice President of Compliance and Corporate Secretary.

 

Appointment of Brian Cogley as New Chief Financial Officer

 

On May 17, 2023, the Company announced that Brian Cogley, age 37, was appointed as the Company’s new Chief Financial Officer, effective immediately.

 

Mr. Cogley has over 15 years of accounting and finance experience, having previously held positions of increasing authority at two “Big 4” accounting firms and served on the management teams of multiple companies in diverse industries. An accountant by training, Mr. Cogley arrives at Coeptis with a 15-year career in corporate finance and accounting during which he advised and led the financial operations for companies spanning multiple industries including life sciences, pharmaceuticals, financial services, and manufacturing. Most recently, Mr. Cogley was a Senior Manager, Accounting Advisory at CFGI, LLC where he served pharmaceutical and financial services clients in technical accounting implementations and execution, interim Controller roles, interim SEC Reporting Manager roles, segment reporting and carve-out engagements. Prior to joining CFGI, Mr. Cogley held the position of Vice President of Finance & Accounting at NexTier Bank where he was a member of the Company’s senior management team and led its accounting and finance operations, including the general ledger, financial planning and analysis, internal and external financial reporting, and human resources. Prior to NexTier, Mr. Cogley held the position of Global Cash Manager for Calgon Carbon Corporation, where he was responsible for all daily cash decisions across the global enterprise. Before joining Calgon Carbon, Mr. Cogley was a Financial Analyst at TriState Capital Bank where he was responsible for building its Sarbanes-Oxley control environment, SEC/regulatory reporting and new system implementation, while also working on various process improvement projects. Mr. Cogley began his career at KPMG, LLP, providing audit and assurance services to a variety of clients in the financial services industry. Mr. Cogley earned a B.A. with a concentration in accounting and a Master of Business Administration with a concentration in finance from Duquesne University.

 

In connection with Mr. Cogley’s appointment as Chief Financial Officer, the Company entered into an offer letter with Mr. Cogley which provides for, among other things, (i) an initial base salary of $200,000 per year, (ii) eligibility for annual discretionary bonus, (iii) participation in the Company’s stock incentive plan with the number of stock options to be determined and (iv) additional benefits generally available to other salaried employees of the Company. Mr. Cogley’s employment is “at will”.

 

Other than as described in this Current Report, there are no other arrangements or understandings between Mr. Cogley and any other persons pursuant to which he was appointed to the office described above, no family relationship exists among any of the Company’s directors or executive officers and Mr. Cogley and Mr. Cogley does not have any direct or indirect interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

Item 8.01 Other Events

 

On May 17, 2023, the Company issued a press release announcing the departure of Ms. Sheehy and the appointment of Mr. Cogley as the Company’s new Chief Financial Officer. A copy of the press release is included with the Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No. Description

 

99.1 Press Release, dated May 17, 2023
104 Cover Page Interactive Data File (formatted in iXBRL)

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Coeptis Therapeutics Holdings, Inc.
     
Date: May 17, 2023 By: /s/ David Mehalick
   

David Mehalick

Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

 

 EX-99.1 2 coeptis_ex9901.htm PRESS RELEASE

Exhibit 99.1

 

 

 

Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer

 

15-year accounting and finance career spans several sectors including life sciences and underscores financial leadership abilities

 

Wexford, PA, May 17, 2023 – Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or the “Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the appointment of Brian Cogley, MBA, to the position of Chief Financial Officer (CFO) effective immediately. Mr. Cogley brings 15 years of accounting and finance experience to Coeptis, having previously held positions of increasing authority at two “Big 4” accounting firms and served on the management teams of multiple companies in diverse industries. He succeeds Christine Sheehy, who will remain with Coeptis in a senior finance capacity and as Vice President of Compliance and Corporate Secretary.

 

As CFO, Mr. Cogley will be responsible for leading Coeptis’ financial and capital markets activities as the Company targets multiple anticipated growth drivers resulting from the advancement of its SNAP-CAR and GEAR™ programs and other opportunities. Mr. Cogley joins Coeptis’ leadership team alongside Dave Mehalick, Chairman, President and Chief Executive Officer, and Dan Yerace, Director and Vice President of Operations.

 

“We are excited to add Brian to the Coeptis Therapeutics team. Hiring an individual of his capabilities reflects our commitment to bringing in talented individuals with strong track records to our company,” stated Dave Mehalick, President and CEO of Coeptis. “Brian’s extensive and diverse experience advising a range of public and private companies in a variety of industries, including biotechnology and pharmaceuticals, will be instrumental to the growth of Coeptis as we continue to integrate and advance the SNAP-CAR and GEAR programs and as we analyze current and future growth opportunities. On behalf of our Coeptis, I am pleased to welcome Brian and look forward to working with him.”

 

An accountant by training, Mr. Cogley arrives at Coeptis with a 15-year career in corporate finance and accounting during which he advised and led the financial operations for companies spanning multiple industries including life sciences, pharmaceuticals, financial services, and manufacturing. Most recently, Brian was a Senior Manager, Accounting Advisory at CFGI, LLC where he served pharmaceutical and financial services clients in technical accounting implementations and execution, interim Controller roles, interim SEC Reporting Manager roles, segment reporting and carve-out engagements.

 

Prior to joining CFGI, Mr. Cogley held the position of Vice President of Finance & Accounting at NexTier Bank where he was a member of the Company’s senior management team and led its accounting and finance operations, including the general ledger, financial planning and analysis, internal and external financial reporting, and human resources. Prior to NexTier, Mr. Cogley held the position of Global Cash Manager for Calgon Carbon Corporation, where he was responsible for all daily cash decisions across the global enterprise. Before joining Calgon Carbon, Mr. Cogley was a Financial Analyst at TriState Capital Bank where he was responsible for building its Sarbanes-Oxley control environment, SEC/regulatory reporting and new system implementation, while also working on various process improvement projects.

 

Mr. Cogley began his career at KPMG, LLP, providing audit and assurance services to a variety of clients in the financial services industry. Mr. Cogley earned a B.A. with a concentration in accounting and a Master of Business Administration with a concentration in finance from Duquesne University.

 

 

 

 1 

 

 

“I am delighted to join the team at Coeptis Therapeutics, especially at such an exciting time for the Company as it works to advance its diverse pipeline of cell and gene therapies while at the same time exploring expansion opportunities,” stated Mr. Cogley. “I look forward to working with Dave and the rest of the management team, utilizing my financial expertise to help Coeptis achieve its growth potential and generate value for both patients and shareholders.”

 

About Coeptis Therapeutics Holdings, Inc.

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively “Coeptis”), is a biopharmaceutical company developing innovative cell therapy platforms for cancer that have the potential to disrupt conventional treatment paradigms and improve patient outcomes. Coeptis' product portfolio and rights are highlighted by a universal, multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), and intellectual property and knowhow related to the GEAR™ cell therapy and companion diagnostic platforms, which Coeptis is developing with VyGen-Bio and leading medical researchers at the Karolinska Institutet. Coeptis' business model is designed around maximizing the value of its current product portfolio and rights through in-license agreements, out-license agreements and co-development relationships, as well as entering into strategic partnerships to expand its product rights and offerings, specifically those targeting cancer. The Company is headquartered in Wexford, PA. For more information on Coeptis visit https://coeptistx.com/.

 

Cautionary Note Regarding Forward-Looking Statements 

This press release and statements of our management made in connection therewith contain or may contain “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events or performance, and underlying assumptions, and other statements that are other than statements of historical facts. When we use words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, we are making forward-looking statements. Forward-looking statements are not a guarantee of future performance and involve significant risks and uncertainties that may cause the actual results to differ materially and perhaps substantially from our expectations discussed in the forward-looking statements. Factors that may cause such differences include but are not limited to: (1) the inability to maintain the listing of the Company’s securities on the Nasdaq Global Market; (2) the risk that currently explored expansion opportunities, if consummated, disrupts current plans and operations of Company; (3) the inability to recognize the anticipated benefits of the recently closed business combination, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth economically and hire and retain key employees; (4) the risks that the Company’s products in development or those targeted to enter the clinical trial phase fail clinical trials or are not approved by the U.S. Food and Drug Administration or other applicable regulatory authorities; (5) costs related to our ongoing asset development plans and our focus on business expansion opportunities; (6) changes in applicable laws or regulations; (7) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and (8) the impact of the global COVID-19 pandemic on any of the foregoing risks and other risks and uncertainties identified in the Company’s filings with the Securities and Exchange Commission (the “SEC”). The foregoing list of factors is not exclusive. All forward-looking statements are subject to significant uncertainties and risks including, but not limited, to those risks contained or to be contained in reports and other filings filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings made or to be made with the SEC, which are available for review at www.sec.gov. We undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof unless required by applicable laws, regulations, or rules.

 

CONTACTS

 

Coeptis Therapeutics, Inc.

Andy Galy, Sr. VP of Communications

504-416-6965

andy.galy@coeptistx.com

 

Tiberend Strategic Advisors, Inc.

Investors

Daniel Kontoh-Boateng

862-213-1398

dboateng@tiberend.com

 

Media

David Schemelia

609-468-9325

dschemelia@tiberend.com

 

 2 

 

 GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-101.SCH 4 coep-20230517.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 coep-20230517_def.xml XBRL DEFINITION FILE EX-101.LAB 6 coep-20230517_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock [Member] Warrant [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 coep-20230517_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
May 17, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date May 17, 2023
Entity File Number 001-39669
Entity Registrant Name COEPTIS THERAPEUTICS HOLDINGS, INC.
Entity Central Index Key 0001759186
Entity Tax Identification Number 98-1465952
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 105 Bradford Rd
Entity Address, Address Line Two Suite 420
Entity Address, City or Town Wexford
Entity Address, State or Province PA
Entity Address, Postal Zip Code 15090
City Area Code 724
Local Phone Number 934-6467
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock [Member]  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol COEP
Security Exchange Name NASDAQ
Warrant [Member]  
Title of 12(b) Security Warrants, each whole warrant exercisable for one-half of one share of Common Stock for $11.50 per whole share
Trading Symbol COEPW
Security Exchange Name NASDAQ
XML 9 coeptis_8k_htm.xml IDEA: XBRL DOCUMENT 0001759186 2023-05-17 2023-05-17 0001759186 us-gaap:CommonStockMember 2023-05-17 2023-05-17 0001759186 us-gaap:WarrantMember 2023-05-17 2023-05-17 iso4217:USD shares iso4217:USD shares 0001759186 false 8-K 2023-05-17 COEPTIS THERAPEUTICS HOLDINGS, INC. DE 001-39669 98-1465952 105 Bradford Rd Suite 420 Wexford PA 15090 724 934-6467 false false false false Common Stock, par value $0.0001 per share COEP NASDAQ Warrants, each whole warrant exercisable for one-half of one share of Common Stock for $11.50 per whole share COEPW NASDAQ true false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 3 24 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://coeptistx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports coeptis_8k.htm coep-20230517.xsd coep-20230517_def.xml coep-20230517_lab.xml coep-20230517_pre.xml coeptis_ex9901.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "coeptis_8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 27 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "coep-20230517_def.xml" ] }, "inline": { "local": [ "coeptis_8k.htm" ] }, "labelLink": { "local": [ "coep-20230517_lab.xml" ] }, "presentationLink": { "local": [ "coep-20230517_pre.xml" ] }, "schema": { "local": [ "coep-20230517.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 2, "nsprefix": "COEP", "nsuri": "http://coeptistx.com/20230517", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "coeptis_8k.htm", "contextRef": "From2023-05-17to2023-05-17", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://coeptistx.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "coeptis_8k.htm", "contextRef": "From2023-05-17to2023-05-17", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://coeptistx.com/role/Cover" ], "xbrltype": "domainItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001683168-23-003496-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-23-003496-xbrl.zip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end